Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Pharmacodynamic Study of Copanlisib (BAY 80-6946) as Monotherapy in Patients With Non-Hodgkin's Lymphoma and Solid Tumors

NCT02155582 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02155582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02155582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Pharmacodynamic Study of Copanlisib (BAY 80-6946) as Monotherapy in Patients With Non-Hodgkin's Lymphoma and Solid Tumors
Lead sponsor
Bayer
Phase
Phase 1
Overall status
Completed
Start date
August 12, 2014
Completion date
March 16, 2017
Enrollment
63 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

non hodgkin lymphoma